Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.
about
Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureusStaphylococcus aureus in the house fly: temporospatial fate of bacteria and expression of the antimicrobial peptide defensin.Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureusThe guinea pig as a model of infectious diseases.Tissue concentrations of vancomycin and Moxifloxacin in periprosthetic infection in rats.A rat model of polypropylene graft infection caused by Staphylococcus epidermidis.Enterotoxigenic and antibiotic resistance determination of Staphylococcus aureus strains isolated from food handlers in Gaborone, Botswana.Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureusBactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureus.Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infectionEfficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.Effect of ethanol on fluoroquinolone efficacy in a rat model of pneumococcal pneumonia.Synergistic effect of a novel focal hyperthermia on the efficacy of rifampin in staphylococcal experimental foreign-body infection.
P2860
Q33239640-659B8495-5BDF-47B7-AA0A-3A4DF5FEE034Q33935282-1DF6DDFA-B080-43E8-BEE5-35A8A67B3207Q37157166-66EDB448-B311-4FC4-9140-4E5459638317Q37247619-9770AED4-6754-457B-86D0-230BAC4EB477Q37251175-DDE09ECA-722F-48B6-AF12-25DA5085979AQ40128872-95779B19-183E-46D2-80CA-0C34EF51A182Q40317113-9062F3A9-BEB0-4F48-9B08-52CA8A25FCF1Q40799074-3D76FBAA-C33F-4EAA-9A1A-CC67D5EB70B8Q40903164-DAB3B533-611C-4287-9900-6B4C6D111D49Q41833286-CFAD2AB5-08E1-4DA9-8C89-30A4B1C7FBC3Q41913615-488877D6-7C54-4016-A962-8E9A19FA8E83Q42036509-E8EA7936-7FF6-488E-A3F4-C835D24ACE10Q42586714-CF33AA4A-C1E3-471E-AACE-554FD30F20EFQ43181838-861228CC-DC8B-4827-8238-51919CB1CC82Q43275288-0B138ACA-2559-438E-B080-2C2F4D6758CD
P2860
Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Comparison of levofloxacin, al ...... sistant Staphylococcus aureus.
@ast
Comparison of levofloxacin, al ...... sistant Staphylococcus aureus.
@en
Comparison of levofloxacin, al ...... sistant Staphylococcus aureus.
@nl
type
label
Comparison of levofloxacin, al ...... sistant Staphylococcus aureus.
@ast
Comparison of levofloxacin, al ...... sistant Staphylococcus aureus.
@en
Comparison of levofloxacin, al ...... sistant Staphylococcus aureus.
@nl
prefLabel
Comparison of levofloxacin, al ...... sistant Staphylococcus aureus.
@ast
Comparison of levofloxacin, al ...... sistant Staphylococcus aureus.
@en
Comparison of levofloxacin, al ...... sistant Staphylococcus aureus.
@nl
P2860
P50
P1476
Comparison of levofloxacin, al ...... sistant Staphylococcus aureus.
@en
P2093
Carmelo Bisognano
Daniel P Lew
P2860
P304
P356
10.1128/AAC.46.5.1503-1509.2002
P407
P577
2002-05-01T00:00:00Z